James M. Youakim, MD
- 4Articles
- 36.5KReads
- 2010–2015Active
- 19Collaborators
- 443Citations
About
James M. Youakim, MD, has published research focused on the treatment of major depressive disorder, bipolar disorder, and schizophrenia/schizoaffective disorders. His work includes clinical studies on adjunctive therapies such as brexpiprazole and armodafinil for patients with inadequate response to standard antidepressants and cognitive deficits associated with schizophrenia. Between 2010 and 2015, he contributed to randomized, double-blind, placebo-controlled trials addressing these conditions. His frequent collaborators include Aleksandar Skuban, Hans Eriksson, Jane M. Tiller, Margaretta Nyilas, and Mary Hobart.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
